How have economic evaluations in relapsing multiple sclerosis evolved over time? A systematic literature review

A Wiyani, L Badgujar, V Khurana, N Adlard - Neurology and Therapy, 2021 - Springer
Introduction The introduction of disease-modifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) over the last two decades has prompted the economic assessments of …

A cost-effectiveness analysis of the prophylaxis versus on-demand regimens in severe hemophilia A patients under 12 years old in southern Iran

Z Zahedi, M Karimi, K Keshavarz, S Haghpanah… - …, 2021 - Taylor & Francis
Objective This study aimed to compare the cost-effectiveness of these two regimens in
hemophilia A patients, under-12-years-old in southern Iran. Methods A cost-effectiveness …

[HTML][HTML] Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C

Z Goudarzi, A Poursamad, I Karimzadeh, N Jallaly… - Hepatitis …, 2021 - brieflands.com
Background: Hepatitis C virus (HCV) can lead to increased mortality, disability, and liver
transplantation if left untreated, and it is associated with a possible increase in disease …

[PDF][PDF] How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic

A Wiyani, LBVKN Adlard - 2021 - academia.edu
Introduction: The introduction of diseasemodifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) over the last two decades has prompted the economic assessments of …

Economic burden of multiple sclerosis: a cross-sectional study in Iran

M Rezaee, K Keshavarz, S Izadi, A Jafari… - Health Economics …, 2022 - Springer
Abstract Background Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a
heavy socioeconomic burden on societies. This study aimed to determine the economic …